Injective News: 21Shares Files New INJ ETF Proposal
21Shares has filed a new spot Injective (INJ) ETF application with the U.S. Securities and Exchange Commission. The issuer submitted the application on October 20, 2025, making Injective one of the altcoins with multiple ETF filings pending before the SEC. INJ traded around $8.75 as the cryptocurrency appeared to bounce off recent lows amid ETF-driven … Read more